Read articles on the main presentations of the first day of SOLACI-SOCIME 2018 Congress. See the presentation by Dr. Flavio Ribichini, entitled “Usefulness of the functional evaluation with iFR and FFR in bifurcations to define PCI”. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.
SOLACI-SOCIME 2018 | New Indications
Read articles on the main presentations of the first day of SOLACI-SOCIME 2018 Congress. See the presentation by Dr. Flavio Ribichini, entitled “New Indications”. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.
More Evidence For MitraClip in High Risk Patients with Severe Tricuspid Regurgitation
Courtesy of Dr. Carlos Fava. Tricuspid regurgitation (TR) has a negative impact in the long run. Several reports have shown that, in high risk inoperable patients, transcatheter edge-to-edge valve repair with MitraClip is feasible, safe and has good results, but there is still a long way to go. The present study looked at 24 consecutive...
Live Cases, Edited Cases and Lunch Symposiums Sponsored by the Industry
The participation of the medical industry is, undoubtedly, one of the most appealing aspects of the SOLACI-SOCIME 2018 Congress. As usual, the most important companies in this industry have decided to take part in our event. Their contribution is most valuable, as it brings relevance and improves the quality of our scientific presentations. Organize your...
MitraClip in Severe MR: 5 Year Mortality Rate Similar to Surgery
Courtesy of Dr. Carlos Fava. Mitral regurgitation accounts for around 25% of valvular diseases and is a strong mortality predictor in heart disease. One of the challenges of this disease is that patients respond favorably to medical treatment for a long time, which makes hard to establish the right time to perform an intervention without...
Endovascular Therapy in Stroke: Much Evidence and Few Trained Operators
Endovascular therapy is now considered as the standard of care for acute ischemic stroke caused by large vessel occlusion. The time between symptoms onset and reperfusion emerges as the most determinant factor for good clinical outcomes, much more strongly than even in acute myocardial infarction. The saying “time is brain” is even more relevant than...
New Ultra-Thin-Strut DES: Do They Outperform Second-Generation DES?
The new drug-eluting stents (DES) equipped with ultra-thin struts are showing a lower risk of target lesion failure as a result of lower rates of acute myocardial infarction and similar rates of revascularization, according to this meta-analysis soon to be published in Circulation. Such a difference is evidenced at a 1-year follow-up when compared with...
Over 10 Keynote Conferences Confirmed at SOLACI-SOCIME 2018 Congress
We are less than a month away from the most important interventional cardiology event in Latin America. Consequently, we have started to share information on some of the most appealing sessions that you will be able to enjoy in Mexico City from August 1st to 3rd, 2018. On that vein, we are pleased to communicate...
See the presentations of the 2018 Guatemala Sessions
SOLACI thanks the 210 attendees ─physicians, nurses, technicians and other professionals. Without them, we would not have achieved such scientific success at these regional sessions. We would also like to extend our appreciation to the Guatemalan Cardiology Association, to the organization, and to the entire Guatemala for the hospitality and generosity they graciously bestowed upon...
Tricuspid Regurgitation: MitraClip Improves Survival
Courtesy of Dr. Carlos Fava. Tricuspid regurgitation (TR), both isolated or associated with other left valve diseases, has been associated with higher rates of heart failure hospitalization and of cardiovascular death. Recent studies in elderly high-risk patients who underwent percutaneous treatment of left valve disease have shown the presence of TR to be associated with...